Delivery Order SPE2DB22D6029-SPE2DB24FT9XN
- Not listed
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,543.69 firm fixed-price contract is for the supply of Dexmedetomidine 400mcg/100ml-NS 100ml, a medication used for sedation. The contract has an ultimate completion date of November 22, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,203,919 units of the pharmaceutical product Dexmedetomidine 200 mcg/2 ml 2 ml. The order has a ceiling value of $4,104.39 and a period of performance through April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,336.60 firm fixed-price delivery order is for the procurement of DEXMEDETOMIDINE 200 MCG/2 ML 2ML, a medical product, with a completion date of December 15, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,179,047 units of the pharmaceutical product DEXMEDETOMIDINE 200 MCG/2 ML 2ML. The $6,641.38 contract has a completion date of December 27, 2023 and was awarded on December 26, 2023. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a prime contractor that provides...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Dexmedetomidine 200 mcg/2 mL in 2 mL vials, with a ceiling value of $1,359.50. This is a firm fixed-price delivery order with an ultimate completion date of September 30, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,648.87 firm fixed-price delivery order is for the supply of DEXMEDETOMIDINE 200MCG/50ML-NS 50ML, a medical product used for various healthcare applications. The contract has an ultimate completion date of January 3, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Dexmedetomidine 200 mcg/2 mL in 2 mL vials. This competitive award, which carries a ceiling value of $1,252.58 and is scheduled for completion by September 30, 2025, is issued under a firm fixed-price delivery order contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,132.76 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of 4563480335 ! DEXMETHYLPHENIDATE ER 30 MG CP 100S, a pharmaceutical product, to support military treatment programs and facilities. This order is part of a larger indefinite delivery contract (IDC) with a potential value of...
- This delivery order, valued at $1,278.66, awards AmerisourceBergen Drug Corp a contract to supply Dexmedetomidine 400mcg/100mL in 100mL vials to the Defense Logistics Agency's Medical Supply Chain. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of September 29, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a firm fixed price Delivery Order contract worth $1,182.71 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This delivery order is for the supply of pharmaceutical products, including a 0.25% 10ML medication, to support military treatment programs and facilities. The contract has a completion date of March 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA,...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB24FT9XNDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The $2,026.56 award is for the delivery of a pharmaceutical product, Dexmedetomidin 400mcg/100ml-NS 100ml, with a completion date of February 6, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC allows Amerisourcebergen to provide a comprehensive range of medications and medical supplies to support military treatment programs and facilities worldwide. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 2/5/24 |